FARAPULSE™ Pulsed Field Ablation System
ConditionParoxysmal AF
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorBoston Scientific Corporation
About this trial
To obtain real world data on the use of, and provide continued evidence on safety and effectiveness of the FARAPULSE™ Pulsed Field Ablation (PFA) system when used per hospitals' standard of care in Chinese population.
Eligibility criteria
Qualifiers
Subjects intended to be treated with the FARAPULSE™ Pulsed Field Ablation system for cardiac tissue ablation, per physician's medical judgement, and as per hospitals' standard of care
Subjects who are willing and capable of providing informed consent
Subjects who are willing and capable of participating in all testing associated with this clinical study at an approved clinical investigational center
Subjects whose age is 18 years or above.
Disqualifiers
Subjects with a current interatrial baffle or patch
Subjects with a known or suspected atrial myxoma
Subjects with a myocardial infarction within 14 days prior to enrollment
Subjects with a recent (within 30 days prior to enrollment) Cerebral Vascular Accident (CVA)
Trial design
Treatments tested in this trial
- FARAPULSE™ Pulsed Field Ablation system
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov